Biogened (WAR:BGD) Cyclically Adjusted Book per Share: zł26.18 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BGD Biogened SA WAR:BGD
69 GF Score
Price zł18.50
GF Value zł23.93
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Biogened Cyclically Adjusted Book per Share?

Biogened WAR:BGD +0.54% 69 Cyclically Adjusted Book per Share is zł26.18 as of Mar. 2026. GuruFocus rates WAR:BGD with a GF Score™ of 69/100 and a GF Value™ of zł23.93 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Biogened's adjusted book value per share for the three months ended in Mar. 2026 was zł19.240. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł26.18 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Biogened's average Cyclically Adjusted Book Growth Rate was -2.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Biogened was 3.10% per year. The lowest was -2.10% per year. And the median was 0.50% per year.

As of today (2026-07-18), Biogened's current stock price is zł18.50. Biogened's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was zł26.18. Biogened's Cyclically Adjusted PB Ratio of today is 0.71.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Biogened was 1.18. The lowest was 0.29. And the median was 0.65.


Biogened  (WAR:BGD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biogened's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=18.50/26.18
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Biogened was 1.18. The lowest was 0.29. And the median was 0.65.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Biogened Cyclically Adjusted Book per Share Related Terms


Biogened Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Biogened's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened Cyclically Adjusted Book per Share Chart

Biogened Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.55 27.51 27.60 26.94 25.79

Biogened Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.97 26.63 26.27 25.79 26.18

WAR:BGD vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biogened's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogened Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biogened's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biogened's Cyclically Adjusted PB Ratio falls into.


WAR:BGD
69GF Score
Biogened SA WAR:BGD
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogened Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biogened's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.24/163.0700*163.0700
=19.240

Current CPI (Mar. 2026) = 163.0700.

Biogened Quarterly Data

Book Value per Share CPI Adj_Book
201606 20.985 99.552 34.374
201609 21.794 99.064 35.875
201612 22.427 100.366 36.438
201703 20.795 101.018 33.569
201706 20.950 101.180 33.765
201709 21.010 101.343 33.807
201712 20.998 102.564 33.385
201803 21.199 102.564 33.705
201806 21.375 103.378 33.717
201809 21.415 103.378 33.780
201812 21.461 103.785 33.720
201903 21.716 104.274 33.961
201906 21.868 105.983 33.647
201909 21.895 105.983 33.689
201912 21.979 107.123 33.458
202003 22.300 109.076 33.339
202006 22.196 109.402 33.085
202009 22.325 109.320 33.302
202012 11.596 109.565 17.259
202103 22.659 112.658 32.798
202106 22.758 113.960 32.565
202109 22.782 115.588 32.141
202112 12.194 119.088 16.697
202203 23.664 125.031 30.864
202206 13.258 131.705 16.415
202209 13.383 135.531 16.102
202212 13.271 139.113 15.556
202303 14.207 145.950 15.873
202306 14.284 147.009 15.845
202309 14.525 146.113 16.211
202312 14.946 147.741 16.497
202403 15.439 149.044 16.892
202406 15.966 150.997 17.243
202409 16.009 153.439 17.014
202412 16.816 154.660 17.730
202503 17.248 157.021 17.912
202506 17.840 157.509 18.470
202509 17.844 158.000 18.417
202512 18.329 158.320 18.879
202603 19.240 163.070 19.240

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of zł26.18 mean?
Biogened (WAR:BGD) has a Cyclically Adjusted Book per Share of zł26.18 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Biogened and its competitors.
Is Biogened's Cyclically Adjusted Book per Share too high?
Biogened's current Cyclically Adjusted Book per Share is zł26.18. Overall, Biogened has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biogened's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Biogened's Cyclically Adjusted Book per Share of zł26.18 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Biogened and its competitors. Biogened's current Cyclically Adjusted Book per Share is zł26.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogened stock overvalued right now?
Based on GuruFocus' analysis, Biogened (WAR:BGD) is currently considered Modestly Undervalued. The stock's GF Value™ is zł23.93, compared to a current price of zł18.50 — trading 22.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is zł26.18. Biogened's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Biogened (WAR:BGD), the current Cyclically Adjusted Book per Share is zł26.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogened (WAR:BGD) Overvalued in 2026?

Based on GuruFocus' analysis, Biogened stock appears to be undervalued. The current stock price of zł18.50 is trading 22.7% below its estimated GF Value™ of zł23.93. GuruFocus considers Biogened to be Modestly Undervalued.

Key valuation signals for WAR:BGD:

  • Cyclically Adjusted Book per Share: zł26.18
  • GF Value™: zł23.93 vs. price of zł18.50 (22.7% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the WAR:BGD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogened Business Description

Address Ulica Pojezierska 99, Lodz, POL, 91-342
Biogened SA is involved in manufacturing cosmetic and hygiene products. It also designs, produces, and markets safe, effective dermo-cosmetics under the Dermedic brand. The company's products include Dermocosmetics, Thermal water, and Pharmaceutical manufacturing conditions.
69GF Score

Get the complete analysis for WAR:BGD

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł18.50
Price
zł23.93
GF Value